<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00413543</url>
  </required_header>
  <id_info>
    <org_study_id>NL11494.075.06</org_study_id>
    <nct_id>NCT00413543</nct_id>
  </id_info>
  <brief_title>Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD) Exacerbation</brief_title>
  <official_title>Early Pulmonary Rehabilitation After Hospitalisation for Acute Exacerbation COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isala</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isala</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to evaluate the effects of early pulmonary rehabilitation within 10 days&#xD;
      after discharge from the hospital after a COPD exacerbation on exercise tolerance,&#xD;
      exacerbations, re-admissions and the quality of life during 6 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design:&#xD;
&#xD;
      One hundred patients with an acute exacerbation of COPD admitted to the regular pulmonology&#xD;
      department via the emergency room will be recruited after they have given written informed&#xD;
      consent. Inclusion criteria are an age &gt; 40 years or ≤ 80 years, at least 10 pack years of&#xD;
      smoking history and COPD at least GOLD II. Each form of physical therapy is accepted outside&#xD;
      pulmonary rehabilitation. Exclusion criteria include participation in a pulmonary&#xD;
      rehabilitation program in the preceding year, comorbidity that can limit exercise training&#xD;
      (for example: invalidating ischaemic heart disease, RA, malignancy and lung embolus),&#xD;
      intolerance to prednisone, history of asthma, non-compliance, findings on chest radiography&#xD;
      other than fitting with signs of COPD and a prior randomisation. During admission patients&#xD;
      will receive standard exacerbation COPD treatment consisting of O2, combivent inhalation,&#xD;
      antibiotics and prednisone. Exercise capacity is measured by a 6 minute walk test performed&#xD;
      at discharge. The COPD GOLD classification is detected with a spirometry after completion of&#xD;
      exacerbation therapy and before randomisation and discharge.&#xD;
&#xD;
      Both measurements are repeated after completion of the pulmonary rehabilitation program at 3&#xD;
      months. Quality of life is evaluated by the following questionnaires at discharge: St. George&#xD;
      respiratory questionnaire (SGRQ), SF-36-scores (short form health survey) and clinical COPD&#xD;
      questionnaire (CCQ). Before discharge, patients are randomised with a computer minimisation&#xD;
      program for pulmonary rehabilitation or usual care with special attendance to age (&lt; 70 years&#xD;
      or ≥ 70 years), sex, length of hospital stay (&lt; 7 days or ≥ 7 days), six minute walk test&#xD;
      distance at discharge (&lt; 100 or ≥ 100 meters) and predicted forced expiratory volume in one&#xD;
      second (FEV1&lt; or ≥ FEV1). Pulmonary rehabilitation will take place within ten days after&#xD;
      discharge and shall be given by a multidisciplinary team (pulmonologist, respiratory nurse,&#xD;
      physical therapist, dietician and a social worker). The program will last 2 hours weekly; 1&#xD;
      hour exercise training and one hour education during 8 weeks. All patients are followed up&#xD;
      after discharge at 3 and 6 months. These questionnaires will be repeated after accomplishment&#xD;
      of the pulmonary rehabilitation program at day 90 and day 180. Readmission rate will be also&#xD;
      evaluated in this period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    enrollment insufficient: lack of motivated patients&#xD;
  </why_stopped>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise tolerance in meters</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exacerbations, readmissions and quality of life during follow-up</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>interventional, rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>'early pulmonary lung rehabilitation'</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>&quot;standard care&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>early pulmonary lung rehabilitation</intervention_name>
    <description>early pulmonary rehabilitation, 10 days after discharge</description>
    <arm_group_label>interventional, rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients ≥ 40 years and &lt; 80 years admitted to the hospital via ER&#xD;
&#xD;
          2. COPD at least Gold II&#xD;
&#xD;
          3. At least 10 pack years of smoking history&#xD;
&#xD;
          4. Physical therapy is tolerated, outside pulmonary rehabilitation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Rehabilitation program &lt; 1 year&#xD;
&#xD;
          2. Intolerance to prednisone&#xD;
&#xD;
          3. Non-compliance&#xD;
&#xD;
          4. Comorbidity limiting pulmonary rehabilitation&#xD;
&#xD;
          5. History of asthma&#xD;
&#xD;
          6. Prior randomisation&#xD;
&#xD;
          7. Findings on X thorax other than fitting with COPD&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Willem Van den Berg, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Isala</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Isala Klinieken</name>
      <address>
        <city>Zwolle</city>
        <state>Overijssel</state>
        <zip>8011 JW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>December 18, 2006</study_first_submitted>
  <study_first_submitted_qc>December 18, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2006</study_first_posted>
  <last_update_submitted>September 17, 2015</last_update_submitted>
  <last_update_submitted_qc>September 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isala</investigator_affiliation>
    <investigator_full_name>Jan W.K. van den Berg</investigator_full_name>
    <investigator_title>pulmonologist</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>exacerbation</keyword>
  <keyword>pulmonary rehabilitation</keyword>
  <keyword>exercise tolerance</keyword>
  <keyword>exacerbations</keyword>
  <keyword>quality of life</keyword>
  <keyword>readmissions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

